Zobrazeno 1 - 10
of 37
pro vyhledávání: '"V. Gontcharova"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Larkin, S. Dalle, M.F. Sanmamed, M. Wilson, J.C. Hassel, H. Kluger, M. Orloff, J.S. Weber, F. Graf Finckenstein, P. Hari, M. Jagasia, H. Yin, W. Shi, G. Sulur, X. Wu, V. Gontcharova, K. Lewis
Publikováno v:
Annals of Oncology. 33:S935-S936
Autor:
J.C. Hassel, A. Sarnaik, J. Chesney, T. Medina, O. Hamid, S. Thomas, M. Wermke, E. Domingo-Musibay, J.M. Kirkwood, J. Larkin, J.S. Weber, A.M. Arance Fernandez, J.F. Rodriguez, I. Thomas, P.G. Corrie, V. Gontcharova, X. Wu, W. Shi, H. Kluger
Publikováno v:
Immuno-Oncology and Technology. 16:100140
Autor:
V. Gontcharova, K. Kunkalla, E. Masteller, Maria Fardis, C. Chartier, Amir A. Jazaeri, M. Blaskovich
Publikováno v:
Annals of Oncology. 31:S642
Autor:
Hadas Dvory-Sobol, Michelle Miller, Evguenia S. Svarovskaia, Ross Martin, Edward Gane, Diana M. Brainard, V. Gontcharova, Robert H. Hyland, Charlotte Hedskog, Hongmei Mo, W. Ouyang, Bin Han
Publikováno v:
Journal of Viral Hepatitis. 22:871-881
Summary Clinical phase II/III studies of the nucleotide analogue HCV NS5B inhibitor sofosbuvir (SOF) have demonstrated high efficacy in HCV-infected patients in combination therapy. To date, resistance to SOF (S282T in NS5B) has rarely been detected
Autor:
Krishna Chodavarapu, Brian P. Doehle, Evguenia S. Svarovskaia, Diana M. Brainard, Michael D. Miller, V. Gontcharova, Charlotte Hedskog, Robert J. de Knegt, Luisa M. Stamm, John G. McHutchison, Javier Crespo Garcia, Joost P.H. Drenth, Hongmei Mo
Publikováno v:
Hepatology, 61, 2, pp. 471-80
Hepatology, 61(2), 471-480. John Wiley & Sons Ltd.
Hepatology, 61, 471-80
Hepatology, 61(2), 471-480. John Wiley & Sons Ltd.
Hepatology, 61, 471-80
Item does not contain fulltext To date, intergenotypic recombinant hepatitis C viruses (HCVs) and their treatment outcomes have not been well characterized. This study characterized 12 novel HCV recombinant strains and their response to sofosbuvir in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3399678ea740806c983d900ca9939bff
https://hdl.handle.net/2066/154753
https://hdl.handle.net/2066/154753
Autor:
Ross Martin, David L. Wyles, E.J. Gane, Christy M. Hebner, Sophia Chiu, Wen Ouyang, Ira M. Jacobson, Neby Bekele, Simin Xu, Hadas Dvory-Sobol, Karin Ku, John G. McHutchison, V. Gontcharova, Neil Parkin, Hongmei Mo, Bin Han, Eric Lawitz, Evguenia S. Svarovskaia, William T. Symonds, Diana M. Brainard, David R. Nelson, Michael D. Miller
Data demonstrate a uniform susceptibility of subject-derived hepatitis C virus (HCV) to sofosbuvir, and also show that selection of sofosbuvir-resistant HCV is exceedingly rare and is associated with a significant reduction in viral fitness. Backgrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f31e0cc6d8113a1813077ceacffcba
https://europepmc.org/articles/PMC6433438/
https://europepmc.org/articles/PMC6433438/
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (7)
The article considers the issues of implementation of the point-of-care technology (diagnostic testing at treatment place) in modern clinic of emergency states. The economic practicability and advantages of point-of-care tests as compared with analys
Autor:
Michael D. Miller, E.S. Svarovskaia, John G. McHutchison, V. Gontcharova, Ross Martin, E.J. Lawitz, Hongmei Mo, Hadas Dvory-Sobol
Publikováno v:
Journal of Hepatology. 60:S498
Autor:
Diana M. Brainard, Brian P. Doehle, C. Hedsko, Evguenia S. Svarovskaia, Krishna Chodavarapu, William T. Symonds, V. Gontcharova, Hongmei Mo, Michael D. Miller
Publikováno v:
Journal of Hepatology. 60:S142